EP 1761252 A1 20070314 - MATRIX-CONTROLLED TRANSDERMAL THERAPEUTIC SYSTEM BASED ON AN ADHESIVE FOR ADMINISTERING NORELGESTROMIN OR THE COMBINATION THEREOF WITH AN ESTROGEN
Title (en)
MATRIX-CONTROLLED TRANSDERMAL THERAPEUTIC SYSTEM BASED ON AN ADHESIVE FOR ADMINISTERING NORELGESTROMIN OR THE COMBINATION THEREOF WITH AN ESTROGEN
Title (de)
MATRIXKONTROLLIERTES TRANSDERMALES THERAPEUTISCHES SYSTEM AUF BASIS EINES KLEBSTOFFS ZUR VERABREICHUNG VON NORELGESTROMIN ODER DESSEN KOMBINATION MIT EINEM ESTROGEN
Title (fr)
SYSTEME THERAPEUTIQUE TRANSDERMIQUE A COMMANDE MATRICIELLE A BASE D'UN AGENT ADHESIF POUR PERMETTRE L'ENRICHISSEMENT EN NORELGESTROMINE OU SA COMBINAISON AVEC UN OESTROGENE
Publication
Application
Priority
- EP 2005006213 W 20050609
- DE 102004028284 A 20040611
Abstract (en)
[origin: WO2005120470A1] The invention relates to a transdermal therapeutic system comprising an agent-impermeable coating, an agent-containing matrix, and a removable protective layer. The matrix contains or is composed of norelgestromin, an optional estrogen, a pressure-sensitive melt adhesive, and optional auxiliary substances.
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/57 (2006.01); A61P 5/24 (2006.01); A61P 15/12 (2006.01); A61K 47/10 (2006.01)
CPC (source: EP US)
A61K 9/7053 (2013.01 - EP US); A61K 31/57 (2013.01 - EP US); A61P 5/24 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/12 (2017.12 - EP); A61K 47/10 (2013.01 - EP US)
Citation (search report)
See references of WO 2005120470A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005120470 A1 20051222; DE 102004028284 A1 20060105; EP 1761252 A1 20070314; US 2008279915 A1 20081113
DOCDB simple family (application)
EP 2005006213 W 20050609; DE 102004028284 A 20040611; EP 05753157 A 20050609; US 62904605 A 20050609